Exchange: NASDAQ·

ITOSITeos Therapeutics Inc

$0.00
$0.00
(0.00%)
Today
Reported EarningsApr 28
Mkt Cap$448.68M
Vol11.01M
News
all
press releases
Muna Therapeutics Announces CEO Transition as Clinical Pipeline Advances
Muna Therapeutics Announces CEO Transition as Clinical Pipeline Advances Muna Therapeutics Announces CEO Transition as Clinical Pipeline Advances PR Newswire COPENHAGEN, Denmark and BOSTON, June 30, 2026 After leading Muna's evolution into a clinical-stage company, Rita Balice-Gordon, Ph.D., will...
PR Newswire
More News
iTeos Therapeutics (ITOS) Upgraded to Buy: Here's What You Should Know
Zacks
iTeos Therapeutics To Wind Down Operations, Explores Asset Sale: Retail Believes It’s ‘Worth More Selling It Off’
The company decided to wind down operations as part of a review of strategic alternatives aimed at maximizing shareholder value after its collaboration with GSK plc ended.
Stocktwits
GSK Inks $2B Deal With Boston Pharmaceuticals to Buy Liver Disease Drug
Zacks
iTeos, GSK End Collaboration On Experimental Cancer Therapy Development: But Retail’s Extremely Bullish
The two companies worked together to assess the Belrestotug + Dostarlimab doublet in treating a specific type of lung cancer.
Stocktwits
<
1
>

Advertisement|Remove ads.